ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.004,15
0,00%
S&P 500
5.868,55
-0,22%
Dow Jones
42.392,27
-0,36%
Euro vs US Dollar
1,0282
0,14%
Bitcoin
96.338,16
-0,58%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Avalon GloboCare Corporation (ALBT)

  7. Avalon GloboCare Corporation (ALBT) News

ALBT

Avalon GloboCare (ALBT)

Avalon GloboCare Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ALBT
DatumZeitQuelleÜberschriftSymbolFirma
26/12/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
19/12/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
21/11/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
21/11/202415h00GlobeNewswire Inc.Avalon GloboCare Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:ALBTAvalon GloboCare Corporation
18/11/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
01/11/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
31/10/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
31/10/202414h00GlobeNewswire Inc.Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir SalesNASDAQ:ALBTAvalon GloboCare Corporation
29/10/202422h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
25/10/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
25/10/202415h00GlobeNewswire Inc.Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired DrivingNASDAQ:ALBTAvalon GloboCare Corporation
24/10/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
24/10/202415h00GlobeNewswire Inc.Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance PlanNASDAQ:ALBTAvalon GloboCare Corporation
11/10/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
09/10/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
09/10/202415h00GlobeNewswire Inc.Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer DeviceNASDAQ:ALBTAvalon GloboCare Corporation
28/08/202422h31Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ALBTAvalon GloboCare Corporation
19/08/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALBTAvalon GloboCare Corporation
15/08/202422h05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ALBTAvalon GloboCare Corporation
14/08/202423h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ALBTAvalon GloboCare Corporation
14/08/202414h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
14/08/202414h00GlobeNewswire Inc.Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter DeviceNASDAQ:ALBTAvalon GloboCare Corporation
31/07/202414h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
31/07/202414h00GlobeNewswire Inc.Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid AddictionNASDAQ:ALBTAvalon GloboCare Corporation
18/07/202415h00GlobeNewswire Inc.Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.usNASDAQ:ALBTAvalon GloboCare Corporation
18/07/202414h37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
16/07/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
20/06/202414h30GlobeNewswire Inc.Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 ConferenceNASDAQ:ALBTAvalon GloboCare Corporation
05/06/202422h54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
24/05/202423h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
 Showing the most relevant articles for your search:NASDAQ:ALBT

Kürzlich von Ihnen besucht

TG
432
Arbor Metals
CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
ALV
Allianz
DBI
MDAX
MDAX
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
COIN
XRPUSD
Ripple
NYSE
DIS
Walt Disney
TG
CBK
Commerzbank
TG
BAYN
Bayer
TG
DBK
Deutsche Bank
TG
D7G
Nel ASA
TG
RHM
Rheinmetall
NASDAQ
MSFT
Microsoft
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten